Parkside Financial Bank & Trust’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Parkside Financial Bank & Trust's CLB Position: Q2 2026 in Review
Parkside Financial Bank & Trust held its Core Laboratories (CLB) position steady in Q2 2026 at 61 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #2525.
Parkside Financial Bank & Trust first reported a position in CLB in Q2 2020 and has held it in 20 quarters since. The position peaked at $10K in Q1 2022. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Parkside Financial Bank & Trust held 61 shares of Core Laboratories worth $712 as of Q2 2026.
- Parkside Financial Bank & Trust left its Core Laboratories share count unchanged in Q2 2026.
- Core Laboratories made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2525 holding.
- Parkside Financial Bank & Trust first reported a position in Core Laboratories in Q2 2020 and has held it in 20 quarters since.
- Parkside Financial Bank & Trust's Core Laboratories position peaked at $10K in Q1 2022.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.